(Q40739451)

23 September 2017

1 reference

title

Infections in cancer patients: some controversial issues (English)

1 reference

23 September 2017

S C Schimpff

1

1 reference

23 September 2017

D A Scott

series ordinal

2

1 reference

23 September 2017

J C Wade

series ordinal

3

1 reference

23 September 2017

publication date

1 March 1994

1 reference

Supportive Care in Cancer

23 September 2017

published in

1 reference

23 September 2017

volume

2

1 reference

23 September 2017

issue

2

1 reference

23 September 2017

page(s)

94-104

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00572090

23 September 2017

exact match

0 references

cites work

Prospective randomized trial of piperacillin monotherapy versus carboxypenicillin-aminoglycoside combination regimens in the empirical treatment of serious bacterial infections

1 reference

https://api.crossref.org/works/10.1007%2FBF00572090

Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00572090

Prospective randomized comparison of three antibiotic regimens for empirical therapy of suspected bacteremic infection in febrile granulocytopenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00572090

Ceftazidime versus imipenem-cilastatin as initial monotherapy for febrile neutropenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00572090

Prophylactic intravenous amphotericin B in neutropenic autologous bone marrow transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00572090

Vancomycin is not an essential component of the initial empiric treatment regimen for febrile neutropenic patients receiving ceftazidime: a randomized prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00572090

Gram-positive infections and the use of vancomycin in 550 episodes of fever and neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00572090

Ceftazidime Monotherapy for Empiric Treatment of Febrile Neutropenic Patients: A Metaanalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00572090

Origin of infection in acute nonlymphocytic leukemia. Significance of hospital acquisition of potential pathogens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00572090

Staphylococcus epidermidis: an increasing cause of infection in patients with granulocytopenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00572090

Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation: a double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00572090

Oral Acyclovir for Prevention of Herpes Simplex Virus Reactivation After Marrow Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00572090

Beta-lactam antibiotic therapy in febrile granulocytopenic patients. A randomized trial comparing cefoperazone plus piperacillin, ceftazidime plus piperacillin, and imipenem alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00572090

Combination of amikacin and carbenicillin with or without cefazolin as empirical treatment of febrile neutropenic patients. The International Antimicrobial Therapy Project Group of the European Organization for Research and Treatment of Cancer

21 January 2018

1 reference

12 December 2020

Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. The EORTC international antimicrobial therapy project group

1 reference

12 December 2020

Herpes simplex virus infection in the immunocompromised cancer patient

1 reference

12 December 2020

Serum bactericidal test in volunteers--a review

1 reference

12 December 2020

Imipenem compared with ceftazidime plus vancomycin as initial therapy for fever in neutropenic children with cancer

1 reference

12 December 2020

Anti-endotoxin monoclonal antibodies

1 reference

12 December 2020

A Comparison of Imipenem to Ceftazidime With or Without Amikacin as Empiric Therapy in Febrile Neutropenic Patients

1 reference

12 December 2020

Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia

1 reference

12 December 2020

Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients. European Organization for Research and Treatment of Cancer (EORTC) International Antimicrobial Therapy Cooperative Group and the National Canc

1 reference

12 December 2020

Ketoconazole versus nystatin plus amphotericin B for fungal prophylaxis in severely immunocompromised patients

1 reference

12 December 2020

Significance of serum bactericidal activity in gram-negative bacillary bacteremia in patients with and without granulocytopenia

1 reference

12 December 2020

Adherent microorganisms on lumenal surfaces of long-term intravenous catheters. Importance of Staphylococcus epidermidis in patients with cancer

1 reference

12 December 2020

A comparison of trimethoprim-sulfamethoxazole plus nystatin with gentamicin plus nystatin in the prevention of infections in acute leukemia

1 reference

12 December 2020

Prophylaxis of Oral Candidiasis With Clotrimazole Troches

1 reference

12 December 2020

Vancomycin, ticarcillin, and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile, neutropenic children with cancer

1 reference

12 December 2020

Septicemia and Shock Syndrome Due to Viridans Streptococci: A Case-Control Study of Predisposing Factors

1 reference

12 December 2020

Experimental basis for use of fluconazole for preventive or early treatment of disseminated candidiasis in granulocytopenic hosts

1 reference

12 December 2020

Significance of antimicrobial synergism for the outcome of gram negative sepsis

1 reference

12 December 2020

A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation

1 reference

12 December 2020

Prophylactic fluconazole and Candida krusei infections

1 reference

12 December 2020

Concept of empiric therapy with antibiotic combinations. Indications and limits

1 reference

12 December 2020

A study of the value of simple protective isolation in patients with granulocytopenia

1 reference

12 December 2020

Successful Chemoprophylaxis forPneumocystis cariniiPneumonitis

1 reference

12 December 2020

Occasional notes. Please don't eat the salads

1 reference

12 December 2020

Prevention of gram-positive infections after bone marrow transplantation by systemic vancomycin: a prospective, randomized trial

1 reference

12 December 2020

Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin.

1 reference

12 December 2020

Infection prevention in acute nonlymphocytic leukemia. Laminar air flow room reverse isolation with oral, nonabsorbable antibiotic prophylaxis

1 reference

12 December 2020

Management of infection in patients with acute leukemia

1 reference

12 December 2020

A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group

1 reference

12 December 2020

Antibiotic synergism and response in gram-negative bacteremia in granulocytopenic cancer patients

1 reference

12 December 2020

Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Hematopoietic Reconstitution after High-Dose Chemotherapy and Autologous Bone Marrow Transplantation

1 reference

12 December 2020

Prevention of bacterial infection in neutropenic patients with hematologic malignancies. A randomized, multicenter trial comparing norfloxacin with ciprofloxacin. The GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche Maligne dell'Adult

1 reference

12 December 2020

Synergistic combinations of antibiotics in gram-negative bacillary infections.

1 reference

12 December 2020

Anti-endotoxin monoclonal antibodies--a second look

1 reference

12 December 2020

Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia

1 reference

12 December 2020

A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia

1 reference

12 December 2020

Increase inCandida kruseiInfection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole

1 reference

12 December 2020

Low-dose amphotericin B prophylaxis against invasive Aspergillus infections in allogeneic marrow transplantation

1 reference

12 December 2020

Effect of Granulocyte Colony-Stimulating Factor after Intensive Induction Therapy in Relapsed or Refractory Acute Leukemia

1 reference

12 December 2020

Evolution of antifungal agents: past, present, and future

1 reference

12 December 2020

Empiric use of vancomycin during prolonged treatment-induced granulocytopenia. Randomized, double-blind, placebo-controlled clinical trial in patients with acute leukemia

1 reference

12 December 2020

Imipenem therapy of Pseudomonas aeruginosa bacteraemia in neutropenic rats

1 reference

12 December 2020

Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group

1 reference

12 December 2020

Cost-effectiveness of monoclonal antibodies to gram-negative endotoxin in the treatment of gram-negative sepsis in ICU patients

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00572090

1 reference

Dimensions Publication ID

23 September 2017

1015303344

0 references

1 reference